Overview

·China’s Biggest Insulin and Enzyme Preparations Production Base

·China’s Biggest Instant Food and Portable Water Production Base

·China’s Biggest Vaccine Industrialization Base

Covering Eight Growth Priorities of the Pharmaceutical Industry:

Biomedicine, Chemical Drugs, Traditional Chinese Medicine(TCM), NaturalMedicines, Medical Devices, In-vitro Diagnostics, CRO Services, Biotechnology

In 2021, TEDA saw a output value of 66.54 billion yuanfrom its healthcare industry.

After 30 years of development, five major industrialclusters have been formed in the fields of biomedicine, medical devices,pharmaceutical R&D outsourcing, food and drink, and big health.

Biomedicine

Medical Devices

CRO

Food & Bevearges